Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Tiziana Life |
Description | Developing alternative routes of immunotherapies with innovative drugs for neurodegenerative NASDAQ: TLSA About Company Background Corporate Strategy Our Team Focus Secondary Progressive Multiple Sclerosis Crohn’s Disease Type 1 Diabetes Pulmonary |
Keywords | N/A |
WebSite | tizianalifesciences.com |
Host IP | 98.129.229.4 |
Location | United States |
Site | Rank |
US$15,932,729
Last updated: 2023-05-01 02:38:38
tizianalifesciences.com has Semrush global rank of 664,312. tizianalifesciences.com has an estimated worth of US$ 15,932,729, based on its estimated Ads revenue. tizianalifesciences.com receives approximately 1,838,392 unique visitors each day. Its web server is located in United States, with IP address 98.129.229.4. According to SiteAdvisor, tizianalifesciences.com is safe to visit. |
Purchase/Sale Value | US$15,932,729 |
Daily Ads Revenue | US$14,708 |
Monthly Ads Revenue | US$441,215 |
Yearly Ads Revenue | US$5,294,569 |
Daily Unique Visitors | 122,560 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
tizianalifesciences.com. 599 | A | tizianalifesciences.com. 599 | IP: 98.129.229.4 |
tizianalifesciences.com. 3600 | NS | tizianalifesciences.com. 3600 | NS Record: ns33.domaincontrol.com. |
tizianalifesciences.com. 3600 | NS | tizianalifesciences.com. 3600 | NS Record: ns34.domaincontrol.com. |
tizianalifesciences.com. 3600 | MX | tizianalifesciences.com. 3600 | MX Record: 0 tizianalifesciences-com.mail.protection.outlook.com. |
tizianalifesciences.com. 3600 | TXT | tizianalifesciences.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
NASDAQ: TLSA About Company Background Corporate Strategy Our Team Focus Secondary Progressive Multiple Sclerosis Crohn’s Disease Type 1 Diabetes Pulmonary Fibrosis KRAS+ NSCLC Platform Pipeline Foralumab (TZLS-401) Anti IL-6R mAb (TZLS-501) Milciclib (TZLS-201) Investors Stock Information Presentations Press Releases Financial Information Investor Calendar Governance Shareholder Services News Careers Contact Developing alternative routes of immunotherapies with innovative drugs for neurodegenerative diseases. Learn more about Tiziana Tiziana Investor Deck Scientific Presentations and Updates In the Media 23 March 2023 16 March 2023 16 March 2023 09 March 2023 Tiziana Life Sciences Announces Findings from Intranasal Anti-CD3 mAb Treatment in Intracerebral Hemorrhage at the Annual American Academy of Neurology Conference 27 April 2023 There are no effective treatments for intracerebral hemorrhage (ICH), which has a 30% to 40% mortality rate Intranasal anti-CD3 mAb treatment showed a |
HTTP/1.1 200 OK Server: Apache/2.4 Content-Type: text/html; charset=UTF-8 Date: Sat, 23 Oct 2021 18:13:22 GMT X-XSS-Protection: 1; mode=block Transfer-Encoding: chunked X-Content-Type-Options: nosniff Connection: Keep-Alive Set-Cookie: X-Mapping-hcneaomb=44255B18352244711D107625BC0C7375; path=/ X-Frame-Options: deny |
Domain Name: TIZIANALIFESCIENCES.COM Registry Domain ID: 1852199906_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-04-29T20:30:53Z Creation Date: 2014-03-27T11:06:12Z Registry Expiry Date: 2022-03-27T11:06:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:12:34Z <<< |